The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical efficacy of cabozantinib plus nivolumab (CaboNivo) and CaboNivo plus ipilimumab (CaboNivoIpi) in patients (pts) with chemotherapy-refractory metastatic urothelial carcinoma (mUC) either naïve (n) or refractory (r) to checkpoint inhibitor (CPI).
 
Rosa Nadal
No Relationships to Disclose
 
Amir Mortazavi
Honoraria - Motive Medical Intelligence
Consulting or Advisory Role - Genentech/Roche
Research Funding - Acerta Pharma (Inst); Genentech/Roche (Inst); Merck (Inst); Novartis (Inst); Seagen (Inst)
 
Mark N. Stein
Research Funding - Abbvie (Inst); Advaxis (Inst); Astellas Pharma (Inst); Bavarian Nordic (Inst); Janssen Oncology (Inst); Medivation/Astellas (Inst); Merck Sharp & Dohme (Inst); Oncoceutics (Inst); Suzhou Kintor Pharmaceuticals (Inst); Suzhou Kintor Pharmaceuticals (Inst)
 
Sumanta K. Pal
Honoraria - Astellas Pharma; Medivation; Novartis
Consulting or Advisory Role - Astellas Pharma; Aveo; Bristol-Myers Squibb; Eisai; Exelixis; Genentech; Ipsen; Myriad Pharmaceuticals; Novartis; Pfizer
Research Funding - Medivation
 
Daniel K Lee
No Relationships to Disclose
 
Howard L. Parnes
No Relationships to Disclose
 
Yang-Min Ning
No Relationships to Disclose
 
Lisa M. Cordes
No Relationships to Disclose
 
Mohammadhadi H. Bagheri
No Relationships to Disclose
 
Ryan Thompson
No Relationships to Disclose
 
Christian Mayfield
No Relationships to Disclose
 
Seth M. Steinberg
No Relationships to Disclose
 
Paul Monk
Consulting or Advisory Role - Bayer; Lilly
Speakers' Bureau - Dendreon; Sanofi
Research Funding - Prometheus
Travel, Accommodations, Expenses - Lilly
 
Primo Lara
Honoraria - Pfizer
Consulting or Advisory Role - Abbvie; AstraZeneca; Bayer; Bristol-Myers Squibb; Celgene; Exelixis; Genentech/Roche; Janssen; Novartis; Pfizer; Turnstone Bio
Research Funding - Aragon Pharmaceuticals (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Heat Biologics (Inst); Incyte (Inst); Janssen Biotech (Inst); Merck (Inst); Millennium (Inst); Pharmacyclics (Inst); Polaris (Inst); TRACON Pharma (Inst)
 
Rene Costello
No Relationships to Disclose
 
Piyush K. Agarwal
No Relationships to Disclose
 
Donald Bottaro
No Relationships to Disclose
 
William L. Dahut
No Relationships to Disclose
 
Andrea B. Apolo
No Relationships to Disclose